GLUT1 and GRP78 are reported to be up-regulated in several cancers and a high GLUT1 expression corresponds with a poor prognosis in CRC (Yamamoto et al, 1990; Haber et al, 1998; Li & Lee, 2006). This evidence concerns the gene SLC2A1 and cancer.